Home
Innovative Cellular Therapeutics Holdings reported a 12.3% stake in Lyell Immunopharma LYEL · 3,000,000 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 12.3%
- Last report
- 9.8% · filed 25/11/13
- Shares held
- 3,000,000 sh
- Class
- Common Stock, par value $0.0001
- Event date
- 26/05/18
- Filed
- 26/06/18
12.3% stake · +2.5pp from the last report
- Stake
- 12.3%
- Last report
- 9.8%
- Since last report
- +2.5pp
Lyell Immunopharma trades, last 26 weeks
What else happened in Lyell Immunopharma around then
Filed or reported within 30 days of the trade day · 04/18~06/17Innovative Cellular Therapeutics Holdings's other 5% stake reports
- Innovative Cellular Therapeutics Holdings
5% stakeLyell Immunopharma
5% stakeLyell Immunopharma
LYEL
9.8% stake
1,900,000 sh
9.8% stake
Filed 25/11/13